Figure 1: Changes in TSS-6 (A), VAS symptom (B), VAS QoL (C) and MS (D) according to the immunotherapy application interval during COVİD-19 pandemic.

NS = non-significant; A = TSS-6; B = VAS symptom; C = VAS QoL; D = MS